10:09 AM EST - CareRx Corporation : Today reported its financial results for the fourth quarter ended December 31, 2024. Revenue for the quarter was $92.2 million as compared to $92.8 million for the third quarter of 2024 and $91.1 million for the fourth quarter of 2023. Adjusted EBITDA for the quarter was $7.6 million as compared to $7.8 million for the third quarter of 2024 and $7.5 million for the fourth quarter of 2023: CareRx Corporation
shares T.CRRX are trading down $0.16 at $2.50.
